Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1990-1-31
|
pubmed:abstractText |
We have estimated the half-life of serum growth hormone (GH) in six subjects on 14 occasions following an intravenous bolus injection of either 50 or 500 mU of biosynthetic human growth hormone (B-hGH) while endogenous GH secretion was suppressed by a continuous infusion of somatostatin. The disappearance curve of serum GH was mono-exponential and the mean half-life was 8.9 min (SD 1.5). This is less than previously reported and has important implications for the performance of GH profiles, which should be performed with 10-15 min sampling intervals, and the calculation of pituitary GH secretion rates.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0300-0664
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
443-50
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2574646-Adolescent,
pubmed-meshheading:2574646-Adult,
pubmed-meshheading:2574646-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:2574646-Growth Hormone,
pubmed-meshheading:2574646-Half-Life,
pubmed-meshheading:2574646-Humans,
pubmed-meshheading:2574646-Immunoradiometric Assay,
pubmed-meshheading:2574646-Male,
pubmed-meshheading:2574646-Middle Aged,
pubmed-meshheading:2574646-Recombinant Proteins,
pubmed-meshheading:2574646-Somatostatin
|
pubmed:year |
1989
|
pubmed:articleTitle |
The half-life of exogenous growth hormone after suppression of endogenous growth hormone secretion with somatostatin.
|
pubmed:affiliation |
Endocrine Unit, Middlesex Hospital, London, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|